(VIANEWS) – The NASDAQ opens in less than six hours and TherapeuticsMD‘s pre-market value is already 5.74% up.
The last session, NASDAQ finished with TherapeuticsMD (TXMD) rising 0.97% to $0.35. NASDAQ rose 0.59% to $14,893.75, following the last session’s upward trend on what was a somewhat positive trend exchanging session.
Today’s last reported volume for TherapeuticsMD is 3244219, 46.09% below its average volume of 6018655.
TherapeuticsMD’s last close was $0.35, 87.45% under its 52-week high of $2.75.
TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.35 at 04:24 EST, under its 52-week low of $0.37.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way below its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.
TherapeuticsMD’s last day, last week, and last month’s current intraday variation average was 1.53%, 2.96%, and 4.19%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 7.97% (day), 7.83% (last week), and 9.91% (last month), respectively.
More news about TherapeuticsMD (TXMD).